ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
On Jan. 22, the FDA issued final guidance establishing a new alternative pathway for getting medical devices to…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
I read a written Laboratory Emergency Management Plan, and at the end of the document there was a short section called…
From - Laboratory Industry Report
Late December through January was fairly slow for new product launches in terms of both volume and impactful-ness. Here's a rundown of…
From - Laboratory Industry Report
Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of…
From - Laboratory Industry Report
Last month, the FDA floated a plan to overhaul and modernize the 510(k) premarket review pathway allowing for faster, safer approval of medical devices, including…
From - Laboratory Industry Report
The Theranos debacle hasn't dissuaded retailers from partnering with labs…